Vanguard Group Inc Logic Bio Therapeutics, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.29 - $0.67 $54,006 - $124,773	186,229 Added 59.36%	499,932 $136,000
Q2 2022 Aug 12, 2022	SELL	$0.35 - $0.74 $2,765 - $5,846	-7,900 Reduced 2.46%	313,703 $110,000
Q1 2022 May 13, 2022	SELL	$0.61 - $2.49 $246,904 - $1.01 Million	-404,761 Reduced 55.72%	321,603 $218,000
Q4 2021 Feb 14, 2022	SELL	$2.2 - $4.53 $9,257 - $19,062	-4,208 Reduced 0.58%	726,364 $1.68 Million
Q3 2021 Nov 12, 2021	BUY	$3.85 - $5.09 $56,941 - $75,281	14,790 Added 2.07%	730,572 $3.35 Million
Q2 2021 Aug 13, 2021	BUY	$4.03 - $7.57 $2.88 Million - $5.42 Million	715,782 New	715,782 $3.18 Million

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.